Predictive Value of 5-Methoxytryptophan on Long-Term Clinical Outcome after PCI in Patients with Acute Myocardial Infarction-a Prospective Cohort Study.
Kui HuangXiao-Qin WenWei ZhangJing-Xian WangYan LiangWen-Qing LiYu-Hang WangMiao-Miao LiangAn-Ran JingJing MaXu ZhangYin LiuJing GaoPublished in: Journal of cardiovascular translational research (2024)
Plasma 5-MTP is an independent and protective early biomarker for 1-year MACE and HF events in patients with AMI, especially in younger patients and those with T2DM, STEMI, and baseline HFpEF characteristics.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- st elevation myocardial infarction
- newly diagnosed
- coronary artery disease
- st segment elevation myocardial infarction
- acute coronary syndrome
- chronic kidney disease
- left ventricular
- prognostic factors
- peritoneal dialysis
- antiplatelet therapy
- heart failure
- adipose tissue
- metabolic syndrome
- insulin resistance